We analyzed the distribution characteristics of CD4+ T cells at various stages in patients with CRC and demonstrated the potential of using CD4+ TSCM as an indicator for the diagnosis and early screening of CRC (19–21, 24–26). Here, CD4 is linked to colorectal carcinoma.